This site is intended for health professionals only
Saturday 23 June 2018
Share |

Depo-Provera® use does not appear to increase fracture risk

Study results published in Obstetrics and Gynaecology demonstrates that the use of Depo-Provera® (depot medroxyprogesterone acetate), a long-term contraceptive agent, does not appear to increase fracture risk.(1)
Whilst the use of Depo-Provera® reduces serum oestrogen levels and is associated with significant loss of bone mineral density (BMD), this study shows that it does not appear to have an effect on fracture risk.(1,2)   

Ads by Google